🟢 Heron Therapeutics is trading 6.6% up today without a clear company catalyst

Heron Therapeutics is trading at $0.49 (up 6.6%) without a clear company catalyst, reversing several sessions of mild weakness.

• No fresh company-specific news, earnings reports, FDA decisions, or analyst calls were identified to explain the move.
• The gain occurs despite the broader biotech sector (XBI) trading lower, suggesting the move may be driven by general risk sentiment and volatility in low-priced stocks.
• Broader market indices are trading modestly higher, contrasting with the recent downward trend for the stock.